2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups

Dan Shores is a dedicated attorney and strategist who believes in his clients and the power of their ideas. Dan applies a constructive, problem-solving approach to matters and excels at deciphering key translational aspects of a broad array of technologies to maximize leverage in the context of a client’s desired implementation of such technologies whether as participants in dynamic markets or as first movers.
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital, …
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Hyundai is reportedly in the process of purchasing a large controlling interest in robot innovator Boston Dynamics from SoftBank in
…
Continue Reading Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal
Founders of technology-based companies often recognize very early on that their company’s IP and related technology comprise a significant or…
Continue Reading Emerging Companies: Framework for Leveraging Your IP & Tech
Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10…
Continue Reading World Economic Forum Releases Top 10 Emerging Technologies of 2020
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the…
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.
The fund seeks to…
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups
Founders routinely need to disclose their groundbreaking technologies to third party investors, suitors, collaborators, peers, consultants and others in order…
Continue Reading Key Considerations Regarding Early Disclosures and Patent Protection
Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up…
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual…
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because…
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.